Q4 2028
Ends Dec 29, 2028
Revenue
$32.1B
$31.7B to $32.6B
EPS
4.22
4.15 to 4.29
No analyst count
EPS: No analyst count
Apr 28, 01:48 AM UTC
stable/analyst-estimates
Healthcare
Quote through 2026-08-05T13:30:00Z · Stale
Quote synced 2026-08-05T22:31:44.795559Z
Daily bars through 2026-08-03 · Stale
Daily bars synced 2026-08-04T22:41:42.67136Z
Fundamentals through 2025-12-31 · Stale
Fundamentals synced 2026-08-05T21:39:48.519888Z
Forecasts: Stale
Forecasts synced 2026-04-28T01:48:30.601297Z
Ownership through 2025-12-31 · Stale
Ownership synced 2026-08-05T21:39:48.519888Z
Short interest through 2025-12-31 · Stale
Short interest synced 2026-08-05T21:39:48.519888Z
News through 2026-05-21T04:31:35Z · Stale
News synced 2026-05-21T08:50:04.813249Z
Company profile: Delayed
Company profile synced 2026-05-01T03:44:15.887523Z
Regular-session price
Offline$257.59($255.00 after-hours, +0.02%)
+1.04% regular session
1Y Change
+49.30%
Window
Aug 5, 2025 → Aug 4, 2026
Investment Snapshot
Valuation, growth, profitability, catalysts, and benchmark context.
1D
+1.0%
1M
-1.7%
6M
+8.7%
YTD
+22.9%
1Y
+49.3%
Coverage: 250 bars · Aug 5, 2025 → Aug 4, 2026
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
JNJ is 26.47 pts ahead over the shared 1Y window.
JNJ had 1.83 pts deeper max drawdown than SPY.
JNJ beat SPY in 2 of 2 calendar years shown and trailed in 0.
JNJ
+49.30%
Normalized return
SPY
+22.83%
S&P 500
Excess Return
+26.47 pts
Relative to SPY
JNJ Max Drawdown
-10.96%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for JNJ and SPY.
| Year | JNJ | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +22.94% | +12.67% | +10.27 pts | JNJ |
| 2025 | +21.18% | +9.40% | +11.78 pts | JNJ |
EPS Consensus
4.22
Range 4.15 -> 4.29
No analyst count
vs prior: +22.4%Revenue Outlook
$32.1B
Range $31.7B -> $32.6B
No analyst count
vs prior: +13.1%Price Target
--
-- -> --
No analyst count
Recommendations
--
No recommendation feed
No date
Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Next Earnings
EPS --
Revenue --
No analyst count
EPS Revisions
No recent EPS revision rows
0 revision rows
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from the configured analyst feed.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.